Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses

Overview of attention for article published in Journal of Virology, May 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 2 X users
patent: 25 patents

facebook: 1 Facebook page

Readers on

mendeley: 48 Mendeley

So far, Altmetric has seen 25 patents that reference this research output.

Recombinant neuraminidase and uses thereof

Grant US-12655408-B2

United States of America

16 Jun 2026

Anti-influenza B virus neuraminidase antibodies and uses thereof

Grant US-12545718-B2

United States of America

10 Feb 2026

Swine influenza A virus vaccine comprising a nucleic acid construct comprising first…

Grant JP-7754855-B2

Japan

15 Oct 2025

Mosaic influenza virus hemagglutinin polypeptides and uses thereof

Grant US-12364746-B2

United States of America

22 Jul 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 21 additional patents.